- Home
- ARQT vs REAL Comparison
ARQT vs REAL Comparison
Compare ARQT & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- REAL
- Stock Information
- Founded
- ARQT 2016
- REAL 2011
- Country
- ARQT United States
- REAL United States
- Employees
- ARQT N/A
- REAL N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- REAL Other Specialty Stores
- Sector
- ARQT Health Care
- REAL Consumer Discretionary
- Exchange
- ARQT Nasdaq
- REAL Nasdaq
- Market Cap
- ARQT 1.1B
- REAL 1.2B
- IPO Year
- ARQT 2020
- REAL 2019
- Fundamental
- Price
- ARQT $12.68
- REAL $9.52
- Analyst Decision
- ARQT Strong Buy
- REAL Buy
- Analyst Count
- ARQT 5
- REAL 6
- Target Price
- ARQT $17.00
- REAL $7.04
- AVG Volume (30 Days)
- ARQT 2.1M
- REAL 3.7M
- Earning Date
- ARQT 02-25-2025
- REAL 02-27-2025
- Dividend Yield
- ARQT N/A
- REAL N/A
- EPS Growth
- ARQT N/A
- REAL N/A
- EPS
- ARQT N/A
- REAL N/A
- Revenue
- ARQT $138,708,000.00
- REAL $579,862,000.00
- Revenue This Year
- ARQT $209.03
- REAL $11.26
- Revenue Next Year
- ARQT $49.00
- REAL $8.81
- P/E Ratio
- ARQT N/A
- REAL N/A
- Revenue Growth
- ARQT 182.84
- REAL 2.52
- 52 Week Low
- ARQT $3.11
- REAL $1.52
- 52 Week High
- ARQT $16.20
- REAL $11.38
- Technical
- Relative Strength Index (RSI)
- ARQT 43.06
- REAL 57.83
- Support Level
- ARQT $13.10
- REAL $7.89
- Resistance Level
- ARQT $14.36
- REAL $10.26
- Average True Range (ATR)
- ARQT 0.99
- REAL 0.73
- MACD
- ARQT -0.32
- REAL -0.22
- Stochastic Oscillator
- ARQT 1.95
- REAL 46.77
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's lead product candidate ZORYVE roflumilast cream, has successfully completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the us, generating $1.7 billion in 2023 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 34% of net merchandise value, which excludes returns, cancellations, and first-party sales.